Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
One or and we are at $21. Squeeze above $22 and we hit $35. 800k float. Pullbacks are gifts. You will be kicked out on short. Tested $6.80. Daily is engulfing.
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder.
The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders intended for children, adolescents, and adults. It also focuses on developing CTx-2103 for the treatment of anxiety disorders.
Income
-21.21M
Sales
0.00M
Book/sh
-0.11
Shs Outstand
17.38M
Shs Float
12.32M
Target Price
91.67
DISCLAIMER: ONLY FOR MICK https://investorshub.advfn.com/boards/profilea.aspx?user=1012 *The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions, investments,decisions, or messages posted on this forum. CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION AUTHORS MAY HAVE BUYS OR SELLS WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING. ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN. ANY trade entered into risks the possibility of losing the funds invested. • There are no guarantees when buying or selling any security.Any
DISCLAIMER; JUST TO MAKE SOME THINGS CLEAR I AM NOT AH FINANCIAL ADVISIOR & NOT AH BROKER. I AM JUST AH REGULAR GENT DAT LIKES TO CHAT CHATTER ON MANY COMPANIES. SOME I OWN AH LOT I DON'T. SO NOT RESPONSIBLE ANYTHING I DESCRIBE. THE MICK.